CircuLite, an Australian company, is developing an implantable pump that weighs just one-sixth as much as its smallest predecessor.

About the size of a AA battery, it could ultimately be implanted through a catheterization procedure that is far less invasive than the operations used to place today’s pumps. It could thus be used to treat patients in earlier stages of heart failure, for whom implantation surgery had previously been too risky.